Mundipharma enters Portugal
A Mundipharma inicia atividades em Portugal
Intel ID : 235661
| Synopsis |
|
Mundipharma, a UK-based pharmaceutical company, launched operations in Portugal, as published by newspaper Oje on 18 April 2016, citing its general manager for Portugal, Salvador Lopez. According to the news, the company begins operations with a multidisciplinary team of 24 people, which should increase soon. The first product on the market is to fight asthma.
(content in portuguese)
A Mundipharma, industria farmacêutica britânica, inicia atividades em Portugal, segundo publicou o Oje no dia 18 de Abril de 2016, citando o diretor-geral para Portugal, Salvador Lopez. Segundo a notícia, a empresa arranca a atividade com uma equipa multidisciplinar composta por 24 pessoas que deverá aumentar em breve. O primeiro produto comercializado combate a asma. |
| Intel ID | 235661 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
| Date |
 |
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.